Cargando…
Treatment strategies for neuromyelitis optica
Neuromyelitis optica (NMO) is an autoimmune demyelinating disease with pathogenic autoantibodies that act against the astrocyte water channel protein, i.e. aquaporin-4: the disease is associated with recurrent episodes of optic neuritis (ON) and transverse myelitis, often resulting in severe disabil...
Autores principales: | Huang, Tzu-Lun, Lin, Kung-Hung, Wang, Jia-Kang, Tsai, Rong-Kung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172906/ https://www.ncbi.nlm.nih.gov/pubmed/30305782 http://dx.doi.org/10.4103/tcmj.tcmj_102_18 |
Ejemplares similares
-
Neuromyelitis Optica Spectrum Disorder: From Basic Research to Clinical Perspectives
por: Huang, Tzu-Lun, et al.
Publicado: (2022) -
What's new in neuromyelitis optica spectrum disorder treatment?
por: Chu, Yi-Ching, et al.
Publicado: (2022) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013) -
The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013)